Bangladeshi (DSE) Pharma Industry Analysis
UpdatedMay 26, 2022
DataAggregated Company Financials
Companies16
- 7D-1.5%
- 3M-4.4%
- 1Y14.0%
- YTD-2.2%
Over the last 7 days, the Pharma industry has dropped 1.5%, driven by a pullback from Square Pharmaceuticals of 1.6%. In the past year, the industry has gained 14%. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Bangladeshi Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Fri, 27 May 2022 | ৳531.8b | ৳171.9b | ৳34.6b | 23x |
| Sun, 24 Apr 2022 | ৳561.8b | ৳169.2b | ৳34.3b | 24.9x |
| Tue, 22 Mar 2022 | ৳543.4b | ৳169.2b | ৳34.3b | 26.1x |
| Thu, 17 Feb 2022 | ৳572.0b | ৳169.3b | ৳34.4b | 23.5x |
| Sat, 15 Jan 2022 | ৳554.9b | ৳166.5b | ৳32.5b | 23.9x |
| Mon, 13 Dec 2021 | ৳557.5b | ৳157.6b | ৳30.1b | n/a |
| Wed, 10 Nov 2021 | ৳544.6b | ৳146.9b | ৳26.0b | 25.8x |
| Fri, 08 Oct 2021 | ৳600.1b | ৳145.3b | ৳25.4b | 32.2x |
| Sun, 05 Sep 2021 | ৳554.3b | ৳151.7b | ৳25.7b | 26.6x |
| Tue, 03 Aug 2021 | ৳530.8b | ৳151.7b | ৳25.7b | 27.4x |
| Fri, 07 May 2021 | ৳474.2b | ৳151.7b | ৳25.7b | 18.9x |
| Mon, 08 Feb 2021 | ৳470.5b | ৳148.4b | ৳24.6b | 21.7x |
| Sun, 01 Nov 2020 | ৳388.6b | ৳143.5b | ৳23.9b | 19.6x |
| Wed, 05 Aug 2020 | ৳348.5b | ৳139.4b | ৳23.0b | 19.2x |
| Sat, 09 May 2020 | ৳321.3b | ৳140.3b | ৳24.7b | 13.8x |
| Fri, 31 Jan 2020 | ৳347.7b | ৳135.7b | ৳24.7b | 15.4x |
| Mon, 04 Nov 2019 | ৳373.4b | ৳134.1b | ৳24.1b | 18.8x |
| Thu, 08 Aug 2019 | ৳382.6b | ৳131.0b | ৳23.7b | 17.5x |
Median PE Ratio
18.5x
Current Industry PE
- Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 20.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 15% per year over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Bangladeshi Healthcare industry?
| BD Market | -1.99% | |
| Healthcare | -1.72% | |
| Pharma | -1.51% | |
| Pharma | -1.51% | |
Industry PE
- Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 20.8x.
- Analysts are expecting annual earnings growth of 12%, which is lower than the prior year's growth of 23% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 12% over the next 5 years.
- However this is lower than its past earnings growth rate of 23% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BXPHARMA Beximco Pharmaceuticals | ৳151.40 | 0.8% +৳535.3m | -12.5% | PS11.8x | |
| SILVAPHL Silva Pharmaceuticals | ৳24.30 | 7.5% +৳232.1m | 36.5% | PS28.9x | |
| ACTIVEFINE Active Fine Chemicals | ৳20.80 | 4.0% +৳191.9m | 23.1% | PS94.9x | |
| SILCOPHL Silco Pharmaceuticals | ৳26.00 | 5.3% +৳134.9m | 13.0% | PS34.5x | |
| IBP Indo-Bangla Pharmaceuticals | ৳17.50 | 3.6% +৳68.2m | 0% | PS16.9x |